Data / Drug companies / Health Department, Oklahoma State
Health Department, Oklahoma State: 7 products in the FDA NDC directory, labeler code 83112
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Health Department, Oklahoma State (labeler code 83112) lists 7 products in the FDA National Drug Code Directory, covering 6 finished drugs by generic name. By type: 7 prescription drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on March 7, 2025.
The request: Watch Health Department, Oklahoma State (FDA labeler code 83112): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 83112
- Products in commercial distribution
- 7
- Packages
- 19
- Finished drugs by generic name
- 6
- Prescription products
- 7
- Over the counter products
- 0
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- September 11, 1984
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 6 | 85.7% |
| Other unapproved drugs | 1 | 14.3% |
Products by type
| Type | Products | Share |
|---|---|---|
| Prescription drugs | 7 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Doxycycline hyclate | 2 | 61 |
| Diphenhydramine hcl | 1 | 99 |
| Cefixime | 1 | 7 |
| Amoxicillin | 1 | 35 |
| Doxycycline | 1 | 63 |
| Azithromycin dihydrate | 1 | 20 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Capsule | 4 | 57.1% |
| Tablet, film coated | 3 | 42.9% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
| Class | Products |
|---|---|
| Tetracycline-class Drug | 3 |
| Histamine-1 Receptor Antagonist | 1 |
| Cephalosporin Antibacterial | 1 |
| Penicillin-class Antibacterial | 1 |
| Macrolide Antimicrobial | 1 |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Doxycycline Hyclate | 83112-100 | Tablet, film coated | Generic drugs (ANDA) | March 7, 2025 |
| Banophen | 83112-555 | Tablet, film coated | Other unapproved drugs | January 31, 2025 |
| Doxycycline | 83112-233 | Capsule | Generic drugs (ANDA) | January 1, 2025 |
| Azithromycin Dihydrate | 83112-501 | Tablet, film coated | Generic drugs (ANDA) | February 15, 2024 |
| Cefixime 400 mg | 83112-400 | Capsule | Generic drugs (ANDA) | October 12, 2018 |
| Amoxicillin 500 mg | 83112-500 | Capsule | Generic drugs (ANDA) | November 9, 2005 |
| Doxycycline Hyclate | 83112-985 | Capsule | Generic drugs (ANDA) | September 11, 1984 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.